UNSPSC 51312103: Olopatadine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51312103

Definition

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D27V6190PM, chemically known as 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid but generally known as olopatadine, which bears US NIH Compound Identifier 5281071. European Medicines Agency schedules Olopatadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09431MIG.

Read the full definition

The term OLOPATADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules olopatadine in its Anatomical Therapeutic Chemical (ATC) Classification. OLOPATADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule olopatadine under HS 29329985 and SITC 51569. As of Q4 2014, OLOPATADINE remains the US FDA Preferred Term for this commodity.

Olopatadine bears US NLM identifiers UMLS ID C0527189 and NCI Concept Code C61866. SMILES: O1C2C(/C(=C\CCN(C)C)C3C(C1)CCCC3)CC(CC2)CC(=O)O.

About UNSPSC 51312103

UNSPSC 51312103 Olopatadine is a Commodity code that covers pharmaceutical products, though recent state and local solicitations show activity in related medical supplies and emergency-response therapeutics rather than olopatadine specifically. Seminole County, Florida posted an IFB in mid-2026 for naloxone and drug deactivation systems, indicating that state and local governments use this code tier for procurement of critical pharmaceutical and medical countermeasure supplies. The scope of work under this code involves purchasing finished pharmaceutical products and related medical supplies in quantities ranging from hundreds to thousands of units annually, with requirements for standardized delivery schedules, regulatory compliance documentation such as E-Verify and drug-free workplace certification, and insurance coverage (workers' compensation, commercial general liability, professional liability). County health departments appear to be the primary issuing bodies, though the source provides limited visibility into the broader mix of state departments, municipalities, or school districts that may use this code.

Geographic activity centers on Florida, with Seminole County's recent solicitation as the only documented recent opportunity in the source. The Seminole County IFB (IFB60459723LAS), posted June 30, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract structure included a two-year initial term with one-year renewal option, fixed-fee pricing with unit costs bid per line item, and potential FEMA funding with attendant federal compliance requirements. The source does not identify additional recent opportunities under this code across other states or issuing bodies, limiting visibility into broader market activity.

Quick answers

What is UNSPSC 51312103?

UNSPSC 51312103 is Olopatadine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51312103?

UNSPSC 51312103 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51312103

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code